Focal nodular hyperplasia (FNH) is a benign tumour of the liver, occurring in 0.6-3% of the general population. Most lesions are diagnosed incidentally. With the increasing use and improvement of diagnostic imaging, FNH is being observed more often. It has been shown, using radiological approaches, that most FNH remain stable, or even regress, over a long follow-up period. In addition, it is extremely rare that FNH were discovered in elderly. However, to our knowledge, there is no pathological report illustrating the regression of FNH.
BACKGROUND
Focal nodular hyperplasia (FNH) is a benign tumour of the liver, occurring in 0.6-3% of the general population. 1 It consists of circumscribed nodules of the hyperplastic parenchyma surrounded by more or less continuous fibrous bands radiating from a stellate, fibrotic scar containing dystrophic vessels, mainly thick-walled arteries. Most lesions are diagnosed incidentally. Surgery is not recommended, except in few cases when the tumour compresses neighbouring organs, liver vessels or bile ducts. With the increasing use and improvement of diagnostic imaging, FNH is being observed more often. In the past, FNH has been one of the most challenging hepatic lesions for radiologists; however, recent technical advances in imaging have improved diagnostic accuracy. 2 3 In rare cases, when imaging and liver biopsy have failed to confirm the diagnosis, final diagnosis is achieved only at the time of surgery. 4 However, recently the pathological diagnosis of FNH has been greatly facilitated by the use of glutamine synthetase immunostaining. 5 6 Follow-up studies have been performed only in small series of patients. It has been shown using radiological approaches that most FNH remain stable or even regress over a long follow-up period. [7] [8] [9] In addition, it is extremely rare that FNH were discovered in elderly. However, to our knowledge there is no pathological report illustrating the regression of FNH.
CASE PRESENTATION
A 60-year-old woman was admitted to a local hospital for an acute abdominal pain on 18 February 2009. On CT scan, a large subcapsular haematoma was discovered. There was no haemorrhagic shock. She was admitted to our digestive intensive care unit.
This overweight patient (body mass index 29) was treated for hypertension for a short period of time when she was 16 years old and then since 1994. She was also treated for high cholesterol level (past 10 years) and hypertriglyceridaemia (past 4 years). There was a family history of heart diseases (her mother, the father and brother of the mother; her brother had died at a young age of heart infarcts or arterial hypertension).
She smoked 1 pack of cigarettes/day (for 42 years) and took contraceptive pills for 20 years. She was menopaused at the age of 45 with a substitutive hormonal treatment until 2000.
In 
Pathological results
The resected liver portion had a weight of 2000 g. In the right lobe, the large subcapsular hematoma (15 × 10 cm) was in contact with a subcapsular multinodular necrotico 
DIFFERENTIAL DIAGNOSIS
In this case, no differential diagnosis was discussed. In the absence of a previous diagnosis of FNH, the other diagnosis to be discussed on the MRI were liver cell adenoma and metastasis.
OUTCOME AND FOLLOW-UP
In May 2010, the patient was in good health.
DISCUSSION
Although FNH regression has been described in a couple of case reports, [10] [11] [12] [13] [14] there are only few data describing this phenomenon at the pathological level. [7] [8] [9] In one study, 9 the volumes of FNH were found stable in six cases, decreased in 10 cases and increased in two cases, using CT and MRI observation after a mean follow-up period of 37.6 months. In another report where sonographic follow-up was carried out, 7 it was reported that size reduction of FNH occurred in 8 of 16 patients after a mean followup period of 33 months. In the last published series of patients, 8 with the longest follow-up period (a mean of 42 months), most lesions (70.6%) were stable in size; only 1 lesion (2.9%) increased, and the others (26.5%) decreased or even disappeared over time.
FNH more frequently occurs in women between the ages of 20 and 50. 4 Because of the female predominance and the young age at onset, a role of female hormones has been suggested, but definite evidence has not been provided yet. It has been considered previously that oral contraceptive use and pregnancy might be associated with the enlargement of FNH; however, one study indicated that use of contraceptive pills did not increase the incidence of FNH. 15 Kuo et al 8 investigated the possible factors associated with the evolution in FNH. Although there was no difference between FNH with or without regression, the significant factors associated with disappearance of FNH were older age (p < 0.05), nodule diameter <2 cm (p < 0.05) and longer follow-up time (p value not significant). Multiple logistic regression analysis revealed that older age and longer follow-up time were the independent factors associated with the disappearance of FNH. The association between the disappearance of FNH and older age might be explained by reduced female hormonal levels in older women.
In the present study, although all FNH decreased in size (MRI), on the resected specimen, one was still a classical type of FNH (segment II) and the other one was in the involution process and can be considered as a non-classical FNH.
To our knowledge, this is the first case report showing the pathological changes occurring during the regression phase, with dense fibrous tissue mixed with arteries replacing hepatocytes nodules. FNH is a polyclonal lesion thought to originate from a hyperplastic response to an anomalous vascular supply. 16 The FNH involution is probably controlled by an arterial ischaemia leading to loss of hepatocytes and ducts, which are replaced by fibrotic tissue. The shrunk tissue contained numerous arteries with a very narrow lumen, compared to the extremely thick wall. The loss of hepatocytes explains why the so characteristic FNH glutamine synthetase staining 5 was missing in such regressing FNH. In our case, this characteristic staining was nevertheless observed in the area with preserved hepatocytes.
The diagnosis of involuted FNH would probably be extremely difficult on a liver biopsy if the sampled tissue did not contain hepatocytes. It is likely that with the extensive use of modern imaging techniques, more and more nondiagnosis liver nodules will be identified and perhaps treated. More pathological data are needed to recognise those entirely benign nodules which indeed may completely disappear Learning points ▲ Spontaneous regression of FNH is a phenomenon rarely reported and may be accompanied by the loss of classical criteria for MRI diagnosis.
▲
Pathological diagnosis may be difficult on liver biopsy sample. ▲ Pathological changes occurring during the regression phase of FNH mainly include dense fibrous tissue mixed with arteries replacing hepatocytes nodules.
